RFT

DARPA Awards Phase Four $14.9M Contract to Develop Air Breathing Electric Propulsion for Very Low Earth Orbit Operations

Retrieved on: 
Thursday, April 4, 2024
Principal, Wind, Otter, RFT, Radio, DARPA, Environment, Phase 4, Communications satellite

The award is part of DARPA's Otter program, which aims to develop, demonstrate, and collect on-orbit data for "air breathing" electric propulsion technologies that will harvest ambient low-density air as propellant, enabling extended satellite operations at VLEO altitudes.

Key Points: 
  • The award is part of DARPA's Otter program, which aims to develop, demonstrate, and collect on-orbit data for "air breathing" electric propulsion technologies that will harvest ambient low-density air as propellant, enabling extended satellite operations at VLEO altitudes.
  • The Otter program will build upon a previous effort with DARPA that developed a proof-of-concept thruster prototype for novel, low-cost propellants.
  • "Phase Four has designed and built electric propulsion systems that have been launched on 9 satellites with over 5,300 days of on-orbit flight heritage since the company was founded.
  • We're thrilled to bring that heritage, experience, and innovation in electric propulsion systems to the Otter program."

RF Technologies Attends AONL 2024 Showcasing Help Alert® Healthcare Staff Protection

Retrieved on: 
Tuesday, March 19, 2024
Convention center, American Express, Caregiver, Passport, Knowledge, Hospital, National Safe Place, RFT, Workflow, Safety, Ernest, Parent

BROOKFIELD, Wis., March 19, 2024 /PRNewswire-PRWeb/ -- RF Technologies (RFT®), a leading provider of safety and security solutions for the healthcare industry, is pleased to announce their attendance at the AONL 2024 Trade Show. The event will take place from April 8 to April 11 at the Ernest N. Morial Convention Center in New Orleans, LA. RFT will be exhibiting at booth 440.

Key Points: 
  • RF Technologies will attend AONL 2024 from April 8 to April 11 at the Ernest N. Morial Convention Center in New Orleans, LA.
  • BROOKFIELD, Wis., March 19, 2024 /PRNewswire-PRWeb/ -- RF Technologies (RFT®), a leading provider of safety and security solutions for the healthcare industry, is pleased to announce their attendance at the AONL 2024 Trade Show.
  • "Our Help Alert® staff protection solution helps healthcare facilities provide a more secure environment both inside and outside the buildings on their campus."
  • "We are excited to connect with healthcare professionals at AONL 2024 and to share our knowledge and expertise with them," said Aulds.

BautistaLeRoy Lawyer Uncovered Rooming House Scheme in Missouri

Retrieved on: 
Sunday, February 11, 2024
RFT, Person, Multimedia, Injury, Personal Injuries, Tenant, COVID-19, Judgement, Saint Louis University Hospital, Writing, Civil and political rights, Housing

KANSAS CITY, Mo., Feb. 11, 2024 /PRNewswire-PRWeb/ -- Attorney Ryan Gavin of BautistaLeRoy LLC took Dara Daugherty to court with allegations — and won a $1.8 million judgment against her.

Key Points: 
  • Attorney Ryan Gavin of BautistaLeRoy LLC took Dara Daugherty to court — and won a $1.8 million judgment against her.
  • KANSAS CITY, Mo., Feb. 11, 2024 /PRNewswire-PRWeb/ -- Attorney Ryan Gavin of BautistaLeRoy LLC took Dara Daugherty to court with allegations — and won a $1.8 million judgment against her.
  • The loss of use of his right hand really ended his time at work."
  • The case against Dara Daugherty by our client, James Cole, was litigated under Case No.

MILESTONE ALERT: Bragar Eagel & Squire, P.C. is Investigating Milestone Pharmaceuticals Inc. on Behalf of Milestone Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, January 19, 2024
Telephone, Letter, New Drug Application, Food, Waste, News, P.C, RFT, FDA

NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Milestone Pharmaceuticals Inc. (“Milestone” or the “Company”) (NASDAQ: MIST) on behalf of Milestone stockholders.

Key Points: 
  • NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Milestone Pharmaceuticals Inc. (“Milestone” or the “Company”) (NASDAQ: MIST) on behalf of Milestone stockholders.
  • Our investigation concerns whether Milestone has violated the federal securities laws and/or engaged in other unlawful business practices.
  • Click here to participate in the action.
  • On this news, Milestone’s stock price fell $0.96 per share, or 33.33% in intraday trading.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Milestone Pharmaceuticals Inc.- MIST

Retrieved on: 
Thursday, January 18, 2024
Pomerantz, LLP, Prior, Paroxysmal supraventricular tachycardia, Food, NDA, FDA, Letter, New Drug Application, News, RFT

NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Milestone Pharmaceuticals Inc. (“Milestone” or the “Company”) (NASDAQ: MIST).

Key Points: 
  • NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Milestone Pharmaceuticals Inc. (“Milestone” or the “Company”) (NASDAQ: MIST).
  • The investigation concerns whether Milestone and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

Milestone Pharmaceuticals Investigated by Block & Leviton For Potential Securities Law Violations: Investors Who Have Lost Money Are Encouraged to Contact the Firm

Retrieved on: 
Thursday, January 18, 2024
Letter, Block & Leviton, New Drug Application, Food, Waste, Milestone, Agency, RFT, FDA, Pharmaceutical industry

BOSTON, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Milestone Pharmaceuticals, Inc. (NASDAQ: MIST) for potential securities law violations.

Key Points: 
  • BOSTON, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Milestone Pharmaceuticals, Inc. (NASDAQ: MIST) for potential securities law violations.
  • Investors who have lost money in their Milestone Pharmaceuticals, Inc. investment should contact the firm to learn more about how they might recover those losses.
  • Anyone who purchased Milestone Pharmaceuticals, Inc. stock and has lost money may be eligible, whether or not they have sold their investment.
  • Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Milestone Pharmaceuticals Inc.- MIST

Retrieved on: 
Wednesday, January 10, 2024
Pomerantz, LLP, Paroxysmal supraventricular tachycardia, Food, NDA, FDA, Letter, New Drug Application, News, RFT

NEW YORK, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Milestone Pharmaceuticals Inc. (“Milestone” or the “Company”) (NASDAQ: MIST).

Key Points: 
  • NEW YORK, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Milestone Pharmaceuticals Inc. (“Milestone” or the “Company”) (NASDAQ: MIST).
  • The investigation concerns whether Milestone and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Milestone Pharmaceuticals Inc.- MIST

Retrieved on: 
Tuesday, January 2, 2024
Food, Paroxysmal supraventricular tachycardia, LLP, FDA, RFT, NDA, News, Pomerantz, New Drug Application, Letter

NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Milestone Pharmaceuticals Inc. (“Milestone” or the “Company”) (NASDAQ: MIST).

Key Points: 
  • NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Milestone Pharmaceuticals Inc. (“Milestone” or the “Company”) (NASDAQ: MIST).
  • The investigation concerns whether Milestone and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

Milestone Pharmaceuticals Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Retrieved on: 
Tuesday, December 26, 2023
Waste, FDA, New Drug Application, Food, Agency, Milestone, RFT, Letter, Block & Leviton, Pharmaceutical industry

BOSTON, Dec. 26, 2023 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Milestone Pharmaceuticals, Inc. (NASDAQ: MIST) for potential securities law violations.

Key Points: 
  • BOSTON, Dec. 26, 2023 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Milestone Pharmaceuticals, Inc. (NASDAQ: MIST) for potential securities law violations.
  • Investors who have lost money in their Milestone Pharmaceuticals, Inc. investment should contact the firm to learn more about how they might recover those losses.
  • Anyone who purchased Milestone Pharmaceuticals, Inc. stock and has lost money may be eligible, whether or not they have sold their investment.
  • Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money.

RF Technologies® Attends LeadingAge 2023 in Chicago, IL, Booth 601

Retrieved on: 
Tuesday, October 24, 2023
Knowledge, BLE, Bluetooth Low Energy, RFT, RTLS, Safety, CODE, Nightclub, Nursing

BROOKFIELD, Wis., Oct. 24, 2023 /PRNewswire/ -- RF Technologies (RFT™), a leading provider of safety and security solutions for the healthcare industry, is pleased to announce their attendance at the LeadingAge 2023 Trade Show. The event will take place from November 5 to November 8 at the McCormick Place Convention Center in Chicago, IL. RFT will be exhibiting at booth 601.

Key Points: 
  • RF Technologies will be in attendance at LeadingAge 2023 from November 6 to November 7 at the McCormick Place Convention Center in Chicago, IL.
  • BROOKFIELD, Wis., Oct. 24, 2023 /PRNewswire/ -- RF Technologies (RFT™), a leading provider of safety and security solutions for the healthcare industry, is pleased to announce their attendance at the LeadingAge 2023 Trade Show.
  • "RF Technologies is excited to be a part of LeadingAge 2023," said Ron Kosek, Director of Senior Living Field Sales at RFT.
  • To learn more about RFT and their solutions, visit booth 601 at LeadingAge 2023.